在头部和部状细胞癌的新辅助免疫疗法:当前的证据和未来的前景
Bocheng Zhang1,2, Haolei Tan1,2, Jingyu Kuang3
1Hunan provincial clinical research centre for oncoplastic surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, Hunan, 410013, P. R. China.
Molecular cancer
|November 11, 2025
概括
新辅助免疫疗法为头部和部状细胞癌 (HNSCC) 提供了新的希望,但需要改进. 本综述探讨了临床进展和免疫微环境因素,以提高HNSCC治疗疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 头部和部状细胞癌 (HNSCC) 是一种侵略性的恶性瘤,局部晚期的治疗选择有限.
- 传统疗法显示出低于最佳的疗效,需要新的治疗策略.
- 新辅助免疫疗法为HNSCC提供了一个有前途的方法,但其结果需要增强.
研究的目的:
- 综合审查HNSCC中新辅助免疫疗法的临床研究进展.
- 分析HNSCC中免疫微环境的调节机制.
- 建议未来的研究方向,以提高HNSCC中新辅助免疫疗法的疗效.
主要方法:
- 对临床试验的文献综述和对HNSCC新辅助免疫治疗的研究.
- 对专注于HNSCC中的瘤免疫微环境的研究分析.
- 综合当前的发现,以确定治疗改进的领域.
主要成果:
- 新辅助免疫疗法在HNSCC治疗中显示出潜力,但反应率和长期结果各不相同.
- 瘤免疫微环境显著影响HNSCC的免疫治疗反应.
- 了解免疫逃避机制对于优化治疗策略至关重要.
结论:
- 新辅助免疫疗法是HNSCC治疗的快速发展领域.
- 对免疫微环境调制的进一步研究对于提高治疗疗效至关重要.
- 针对免疫系统的个性化方法有望改善HNSCC患者的治疗结果.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K


